NCLEX vs. DMCRX
NCLEX (Nicholas Limited Edition Fund) and DMCRX (Driehaus Micro Cap Growth Fund) are both Small Cap Growth Equities funds. Over the past 10 years, NCLEX returned 7.44%/yr vs 23.16%/yr for DMCRX. Their correlation of 0.83 suggests significant overlap in exposure. NCLEX charges 0.85%/yr vs 1.38%/yr for DMCRX.
Performance
NCLEX vs. DMCRX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NCLEX achieves a -7.51% return, which is significantly lower than DMCRX's 29.20% return. Over the past 10 years, NCLEX has underperformed DMCRX with an annualized return of 7.44%, while DMCRX has yielded a comparatively higher 23.16% annualized return.
NCLEX
- 1D
- -0.72%
- 1M
- 1.30%
- YTD
- -7.51%
- 6M
- -9.33%
- 1Y
- -12.00%
- 3Y*
- 0.15%
- 5Y*
- -1.65%
- 10Y*
- 7.44%
DMCRX
- 1D
- 1.67%
- 1M
- 5.02%
- YTD
- 29.20%
- 6M
- 25.97%
- 1Y
- 81.98%
- 3Y*
- 31.47%
- 5Y*
- 10.91%
- 10Y*
- 23.16%
NCLEX vs. DMCRX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
NCLEX Nicholas Limited Edition Fund | -7.51% | -10.41% | 11.91% | 17.17% | -23.71% | 19.07% | 22.67% | 27.36% | -0.94% | 19.93% |
DMCRX Driehaus Micro Cap Growth Fund | 29.20% | 31.17% | 30.58% | 11.47% | -33.54% | 22.23% | 86.43% | 34.03% | 2.52% | 24.35% |
Correlation
The correlation between NCLEX and DMCRX is 0.54, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.54 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.72 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.79 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.82 |
Correlation (All Time) Calculated using the full available price history since Nov 20, 2013 | 0.83 |
Over the past year, the correlation between NCLEX and DMCRX has dropped to 0.54 - well below their long-term average of 0.83, suggesting their price drivers have been diverging.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NCLEX vs. DMCRX — Risk / Return Rank
NCLEX
DMCRX
NCLEX vs. DMCRX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Nicholas Limited Edition Fund (NCLEX) and Driehaus Micro Cap Growth Fund (DMCRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| NCLEX | DMCRX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -3.46 | ||
| Sortino ratioReturn per unit of downside risk | -4.07 | ||
| Omega ratioGain probability vs. loss probability | 0.91 | 1.43 | -0.51 |
| Calmar ratioReturn relative to maximum drawdown | -0.49 | 5.44 | -5.94 |
| Martin ratioReturn relative to average drawdown | -0.98 | 18.89 | -19.87 |
Loading charts...
Drawdowns
NCLEX vs. DMCRX - Drawdown Comparison
The maximum NCLEX drawdown since its inception was -48.68%, roughly equal to the maximum DMCRX drawdown of -46.68%. Use the drawdown chart below to compare losses from any high point for NCLEX and DMCRX.
Loading charts...
Drawdown Indicators
| NCLEX | DMCRX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -48.68% | -46.68% | -2.00% |
Max Drawdown (1Y)Largest decline over 1 year | -21.36% | -15.46% | -5.90% |
Max Drawdown (3Y)Largest decline over 3 years | -28.50% | -34.92% | +6.42% |
Max Drawdown (5Y)Largest decline over 5 years | -28.50% | -46.68% | +18.18% |
Max Drawdown (10Y)Largest decline over 10 years | -35.79% | -46.68% | +10.89% |
Current DrawdownCurrent decline from peak | -22.62% | 0.00% | -22.62% |
Average DrawdownAverage peak-to-trough decline | -8.30% | -14.80% | +6.50% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 10.72% | 4.44% | +6.28% |
Volatility
NCLEX vs. DMCRX - Volatility Comparison
The current volatility for Nicholas Limited Edition Fund (NCLEX) is 4.54%, while Driehaus Micro Cap Growth Fund (DMCRX) has a volatility of 10.43%. This indicates that NCLEX experiences smaller price fluctuations and is considered to be less risky than DMCRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NCLEX | DMCRX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.54% | 10.43% | -5.89% |
Volatility (6M)Calculated over the trailing 6-month period | 12.41% | 22.58% | -10.17% |
Volatility (1Y)Calculated over the trailing 1-year period | 17.04% | 29.71% | -12.67% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 19.55% | 28.65% | -9.10% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 19.23% | 28.05% | -8.82% |
NCLEX vs. DMCRX - Expense Ratio Comparison
NCLEX has a 0.85% expense ratio, which is lower than DMCRX's 1.38% expense ratio.
Dividends
NCLEX vs. DMCRX - Dividend Comparison
NCLEX's dividend yield for the trailing twelve months is around 8.15%, less than DMCRX's 10.62% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
DMCRX Driehaus Micro Cap Growth Fund | 10.62% | 13.72% | 3.86% | 0.87% | 8.20% | 48.23% | 19.79% | 14.70% | 33.22% | 8.91% | 0.00% | 4.20% |
NCLEX Nicholas Limited Edition Fund | 8.15% | 7.53% | 2.51% | 2.43% | 6.22% | 16.44% | 5.10% | 5.66% | 10.72% | 7.97% | 10.68% | 8.05% |
Frequently Asked Questions
NCLEX and DMCRX have a correlation of 0.54, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
DMCRX has higher volatility (10.43%) compared to NCLEX (4.54%). In terms of maximum drawdown, NCLEX dropped -48.68% vs DMCRX's -46.68%.
DMCRX currently has the higher Sharpe Ratio (2.84 vs -0.62), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for NCLEX and DMCRX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer